"2"^^ . "\u00DAsp\u011B\u0161n\u00E1 terapie erytrodermick\u00E9 psori\u00E1zy efalizumabem po ukon\u010Den\u00ED l\u00E9\u010Dby infliximabem" . "A lack of efficacy and serious adverse events of biological drugs are reasons to change the therapeutic strategy in psoriasis. Switch of biologicals which are used for the treatment of psoriasis does not have strict rules and partly depends on experience of dermatologist. A case of patient with erythrodermic psoriasis successfuly treated with efalizumab after infliximab discontinuation for severe adverse reaction is reported."@en . "I" . . "Selh\u00E1n\u00ED \u00FA\u010Dinnosti nebo z\u00E1va\u017En\u00E9 vedlej\u0161\u00ED \u00FA\u010Dinky biologick\u00FDch l\u00E9k\u016F jsou d\u016Fvodem pro zm\u011Bnu l\u00E9\u010Debn\u00E9 strategie psori\u00E1zy. Z\u00E1m\u011Bna jednoho biologick\u00E9ho l\u00E9ku za jin\u00FD se ne\u0159\u00EDd\u00ED striktn\u00EDmi pravidly a do zna\u010Dn\u00E9 m\u00EDry vych\u00E1z\u00ED z osobn\u00EDch zku\u0161enost\u00ED dermatologa. P\u0159edkl\u00E1d\u00E1me vlastn\u00ED pozorov\u00E1n\u00ED pacienta s erytrodermickou psori\u00E1zou, u kter\u00E9ho po nucen\u00E9m vysazen\u00ED infliximabu byla zah\u00E1jena \u00FA\u010Dinn\u00E1 terapie efalizumabem." . . "15110" . . "4" . . "Successful Therapa of Erythrodermoc Psoriasis with Efalizumab after Infliximab Discontinuation"@en . "efalizumab; infliximab; psoriasis"@en . "4"^^ . . "\u00DAsp\u011B\u0161n\u00E1 terapie erytrodermick\u00E9 psori\u00E1zy efalizumabem po ukon\u010Den\u00ED l\u00E9\u010Dby infliximabem" . "0009-0514" . "RIV/61989592:15110/09:10224564" . . "CZ - \u010Cesk\u00E1 republika" . . "Successful Therapa of Erythrodermoc Psoriasis with Efalizumab after Infliximab Discontinuation"@en . . . . "Selh\u00E1n\u00ED \u00FA\u010Dinnosti nebo z\u00E1va\u017En\u00E9 vedlej\u0161\u00ED \u00FA\u010Dinky biologick\u00FDch l\u00E9k\u016F jsou d\u016Fvodem pro zm\u011Bnu l\u00E9\u010Debn\u00E9 strategie psori\u00E1zy. Z\u00E1m\u011Bna jednoho biologick\u00E9ho l\u00E9ku za jin\u00FD se ne\u0159\u00EDd\u00ED striktn\u00EDmi pravidly a do zna\u010Dn\u00E9 m\u00EDry vych\u00E1z\u00ED z osobn\u00EDch zku\u0161enost\u00ED dermatologa. P\u0159edkl\u00E1d\u00E1me vlastn\u00ED pozorov\u00E1n\u00ED pacienta s erytrodermickou psori\u00E1zou, u kter\u00E9ho po nucen\u00E9m vysazen\u00ED infliximabu byla zah\u00E1jena \u00FA\u010Dinn\u00E1 terapie efalizumabem."@cs . "84" . "[6546339E4A23]" . "348051" . "\u00DAsp\u011B\u0161n\u00E1 terapie erytrodermick\u00E9 psori\u00E1zy efalizumabem po ukon\u010Den\u00ED l\u00E9\u010Dby infliximabem"@cs . "RIV/61989592:15110/09:10224564!RIV12-MSM-15110___" . "Ditrichov\u00E1, Dagmar" . "\u00DAsp\u011B\u0161n\u00E1 terapie erytrodermick\u00E9 psori\u00E1zy efalizumabem po ukon\u010Den\u00ED l\u00E9\u010Dby infliximabem"@cs . . . "2"^^ . . "Tich\u00FD, Martin" . . . "\u010Cesko-slovensk\u00E1 dermatologie" .